Codeine product indications restricted

Codeine products available over the counter will no longer be indicated for colds, flu, coughs, sore throats and minor painful conditions.

In addition, packs containing more than 32 tablets of effervescent codeine will now only be available on prescription.

The changes form part of a package of measures announced by the MHRA to tackle risks arising from the fact that medicines containing codeine and dihydrocodeine may be addictive.

Medicines packs will now include clear and prominently positioned warnings about the risk of addiction, and the importance of not taking these medicines for longer than three days.

There will also be updated controls on advertising to ensure the new warnings are clearly presented, the MHRA has said.

The MHRA's director of vigilance and risk management of medicines, Dr June Raine, stressed that, taken in the correct manner and for the right purposes, codeine and dihydrocodeine are effective and acceptably safe medicines. ‘However,' she said, ‘these products can be addictive and we are taking action to tackle this risk'.

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins


Already registered?

Sign in

Before commenting please read our rules for commenting on articles.

If you see a comment you find offensive, you can flag it as inappropriate. In the top right-hand corner of an individual comment, you will see 'flag as inappropriate'. Clicking this prompts us to review the comment. For further information see our rules for commenting on articles.

comments powered by Disqus